Do You Use HBOT and Chelation Therapy Together


A new therapeutic approach has been instituted using chelation therapy with HBO for the treatment of atherosclerosis and its clinical manifestations of senility due to cerebral vascular insufficiency, stroke, heart disease, and peripheral vascular occlusive disease. The clinical therapeutic results have been most encouraging.

Atherosclerosis involves a build-up of calcium complexes of mucopolysaccarides, lipoproteins, elastin and collagen in the arteries. This results in the development of insoluble substrates which tend to depress a number of enzyme systems concerned with the oxygenation and energy mechanisms of the arterial wall. The end result is a state of hypoxia in the arterial wall which encourages further calcification.

Chelation therapy is a form of treatment aimed at reducing calcium deposits in the arteries and reversing some of the degenerative processes in the body. The treatment involves injecting small amounts of a synthetic amino acid, disodium ethylenediamine tetraacetic acid (EDTA), into the blood stream. This amino acid has the unique and valuable property of being powerfully attracted to ionic calcium. When EDTA comes in contact with ionic calcium in the body, it binds itself to it. The EDTA-calcium complex is then excreted through the kidneys into the urine and through the liver into the intestinal tract, and finally passes out of the body. This binding property of EDTA provides the basis for chelation therapy. Figure 1 represent how EDTA helps out in the cycle.

The word chelate is derived from the Greek chele which refers to the claw of a crab or lobster, describing the firm, pincer-like binding of certain chemical substances to a bivalent metal or some other mineral. Chelation is specifically defined as the incorporation of a metal or a mineral ion into a heterocyclic ring structure.

Certain chemicals are used in chelation to grasp metals or calcium with this claw-like action so that these elements are encircled or sequestered by a complex ring structure, thereby losing their physiologic and toxic properties. Thus when chelation takes place calcium or some other metal ion comes in contact with the chelating agent (EDTA), becomes imprisoned in the EDTA molecule, and is then excreted from the body in a bound and inert form.

The purpose of the HBO is to increase oxygen to oxygen-starved tissues. By removing ionic calcium with EDTA and providing oxygen with HBO the deranged metabolic processes of the arterial wall are reversed and enzyme function is restored.

McDonagh Medical Center - Privacy Practices